Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07489495 |
| Title | A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) |
| Acronym | LITESPARK-034/LS-034/MK-6482-034 |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ISR | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Macquarie University ( Site 2700) | SUSPENDED | Macquarie University | New South Wales | 2109 | Australia | Details |
| Rambam Health Care Campus ( Site 1600) | RECRUITING | Haifa | 3109601 | Israel | Details | |
| Samsung Medical Center ( Site 2902) | RECRUITING | Seoul | 06351 | South Korea | Details |